For: | Takebayashi K, Aso Y, Inukai T. Role of bile acid sequestrants in the treatment of type 2 diabetes. World J Diabetes 2010; 1(5): 146-152 [PMID: 21537442 DOI: 10.4239/wjd.v1.i5.146] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v1/i5/146.htm |
Number | Citing Articles |
1 |
Xin Ye, Chunlin Qian, Jiannong Liu, Wendy L. St. Peter. Lower Risk of Major Cardiovascular Events Associated with Adherence to Colesevelam HCI. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2013; 33(10): 1062 doi: 10.1002/phar.1317
|
2 |
Jingwei Cai, Bipin Rimal, Changtao Jiang, John Y.L. Chiang, Andrew D. Patterson. Bile acid metabolism and signaling, the microbiota, and metabolic disease. Pharmacology & Therapeutics 2022; 237: 108238 doi: 10.1016/j.pharmthera.2022.108238
|
3 |
Nicolas Bertrand, Patrick Colin, Maxime Ranger, Jeanne Leblond. Supramolecular Systems in Biomedical Fields. 2013; : 483 doi: 10.1039/9781849737821-00483
|
4 |
Toluwani Tella, Carolina Pohl, Kovalchuk Igor. A review on diabetes mellitus: complications, synthetic anti-diabetic agents and herbal treatment. F1000Research 2024; 13: 124 doi: 10.12688/f1000research.141015.1
|
5 |
Eva Heřmánková, Aleš Žák, Lenka Poláková, Radka Hobzová, Róbert Hromádka, Jakub Širc. Polymeric bile acid sequestrants: Review of design, in vitro binding activities, and hypocholesterolemic effects. European Journal of Medicinal Chemistry 2018; 144: 300 doi: 10.1016/j.ejmech.2017.12.015
|
6 |
Zhi‐Xu He, Zhi‐Wei Zhou, Yinxue Yang, Tianxin Yang, Si‐Yuan Pan, Jia‐Xuan Qiu, Shu‐Feng Zhou. Overview of clinically approved oral antidiabetic agents for the treatment of type 2 diabetes mellitus. Clinical and Experimental Pharmacology and Physiology 2015; 42(2): 125 doi: 10.1111/1440-1681.12332
|
7 |
Tamara R. Castañeda, María Méndez, Ian Davison, Ralf Elvert, Uwe Schwahn, Galina Boldina, Corinne Rocher, Petra Scherer, Kuldeep Singh, Dinesh S. Bangari, Mechthilde Falkenhahn, Aimo Kannt, Anish Konkar, Philip J. Larsen, Cynthia Arbeeny, Pradeep K. Dhal, Thomas Hübschle. The Novel Phosphate and Bile Acid Sequestrant Polymer SAR442357 Delays Disease Progression in a Rat Model of Diabetic Nephropathy. The Journal of Pharmacology and Experimental Therapeutics 2021; 376(2): 190 doi: 10.1124/jpet.120.000285
|
8 |
Sunil Rupee, Khemraj Rupee, Ram B. Singh, Carlin Hanoman, Abla Mohammed Ahmed Ismail, Manal Smail, Jaipaul Singh. Diabetes-induced chronic heart failure is due to defects in calcium transporting and regulatory contractile proteins: cellular and molecular evidence. Heart Failure Reviews 2022; 28(3): 627 doi: 10.1007/s10741-022-10271-5
|
9 |
Yingjie Wu, An Zhou, Li Tang, Yuanyuan Lei, Bo Tang, Linjing Zhang. Bile Acids: Key Regulators and Novel Treatment Targets for Type 2 Diabetes. Journal of Diabetes Research 2020; 2020: 1 doi: 10.1155/2020/6138438
|
10 |
Marzieh Daniali, Shekoufeh Nikfar, Mohammad Abdollahi. Advancements in pharmacotherapy options for treating diabetes in children and adolescents. Expert Review of Endocrinology & Metabolism 2024; 19(1): 37 doi: 10.1080/17446651.2023.2290491
|
11 |
Yong Zhang, Lifeng Wang, Jiachao Zhang, Yunxu Li, Qiuwen He, He Li, Xiao Guo, Jianlin Guo, Heping Zhang. Probiotic Lactobacillus casei Zhang ameliorates high-fructose-induced impaired glucose tolerance in hyperinsulinemia rats. European Journal of Nutrition 2014; 53(1): 221 doi: 10.1007/s00394-013-0519-5
|